SUMMARY Thrombospondin (TSP) is a glycoprotein released from platelets after thrombininduced aggregation. Endothelial culture studies suggest that it or a similar protein may also be produced by endothelial cells. The origin of the glycoprotein is therefore of some importance. This report concerns the immunohistochemical localisation of TSP within megakaryocytes and platelets. TSP would appear to be a primary platelet protein of megakaryocyte origin, rather than a substance taken up by the platelet in the circulation. The relation of this molecule to the endothelial glycoprotein remains to be established, but our preliminary immunohistochemical studies suggest that the molecule is also located in vascular endothelium.
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Thrombospondin (TSP) is a glycoprotein thought to be contained in the a granule fraction of human platelets and released after thrombin-induced aggregation. ' 2 It has been suggested that it is very similar to a high molecular weight glycoprotein secreted by bovine aortic3 and human umbilical vein4 endothelial cells in culture.
The source of the protein is of importance. If it is synthesised only in endothelial cells then one must postulate uptake of the protein into the platelet in plasma, as may occur with serotonin. 
Material and methods
Thrombospondin was isolated from platelets as previously described6 and the glycoprotein purified.
Antiserum to the isolated antigen was raised in the rabbit, as for radioimmunoassay.6 Smears of human bone marrow aspirates were used for megakaryoAccepted for publication 2 September 1982 cyte study. They included cases of chronic myeloid leukaemia and of histologically normal marrow, obtained during staging procedure for nonHodgkin's lymphoma. No conditions of known platelet abnormality were used. Platelet-rich plasma (PRP) prepared so as to prevent platelet aggregation7 was smeared on glass slides. Localisation involved the use of an indirect immunofluorescence method.8 The TSP antiserum was used at a dilution of 1/20. As a control, normal rabbit serum was used in place of primary antiserum.
Results
All marrow specimens showed intense fluorescent staining of megakaryocyte cytoplasm (Fig. 1) . The staining could be resolved as a granular cytoplasmic deposit presumably reflecting platelet formation within the demarcation membrane system (Fig. 2) . This was most obvious in those megakaryocytes exhibiting proplatelet extensions, wherein the fluorescence adopted a discrete granular staining pattern. The PRP showed a similar intense fluorescence over platelet cytoplasm. Lack of resolution prevented subcellular localisation vwithin the cytoplasm: thus specific a-granule localisation could not be confirmed. However, samples of platelets studied after induction of the release reaction by thrombin addition to PRP failed to stain in this immunofluorescence assay.
Marrow and non-aggregated platelet-rich plasma TSP antiserum x 1400 treated with normal rabbit serum similarly failed to stain. In marrow sections no cell apart from megakaryocyte and platelet showed immunofluorescent staining.
Discussion
This is the first demonstration of TSP within parent megakaryocyte as well as in platelets by an immunohistochemical method. The glycoprotein was first described as a platelet product released after thrombin-induced aggregation.12 Subcellular localisation must await electronmicroscopic investigation but our findings of abolition of staining after induction of the release reaction, as well as TSP isolation studies2910 suggest that the product is contained within a granules. Its presence in megakaryocytes is particularly important in view of reports suggesting that the molecule is very similar to one secreted by bovine3 and human4 endothelial cells in culture. It has been proposed that the platelet source may represent uptake after release by endotheliumn into plasma." A similar mechanism exists for serotonin,5 but subsequent storage is in the dense bodies; sequestration into a granules would be unique. Since other constituents of the a granule are of megakaryocyte origin and probably represent synthetic products formed in the Golgi apparatus and subsequently packaged as secretory granules, secondary packaging in such organelles after uptake by platelets would seem unlikely. Thus the molecule is, like other granule products such as f thromboglobulin and platelet factor 4,1213 present in the megakaryocyte cytoplasm and in the platelet in both marrow and plasma sites. The role of TSP remains unresolved but platelet aggregation studies suggest that the glycoprotein may be bound to the platelet surface after thrombin stimulation. '4 It may function as a lectin,'5 binding to the surface fibrinogen of platelets during thrombin-mediated aggregation. '6 The high molecular weight of TSP and its migration position on gel electrophoresis suggest similarity to a-2-macroglobulin and fibronectin, but from immunological evidence it is clearly a distinct molecule." Studies of the endothelial glycoprotein suggest that such high molecular weight products are associated with the surface of the cell '7 but are principally found on its abluminal aspect. Since it seems that TSP is of primary platelet origin, it may, like factor VIII antigen and fibronectin, be produced by both megakaryocyte/platelet and endothelium. This concept would be consistent with a role for TSP in platelet endothelial co-operation, likened to the permissive action of factor VIII in mediating platelet adhesion,'8 its presence in platelets and endothelium being a prerequisite of platelet/vessel wall interaction.
It is, however, possible that endothelial siting represents secondary uptake, a concept which is also consistent with a role for TSP in platelet vessel wall interaction, analogous to the endothelial binding by platelet proteins such as PF4. ' Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets Reports suggest that TSP may be produced by both bovine3 and human4 endothelial cells in culture. It is therefore important that the nature of the endothelial protein be determined. Studies were carried out in order to establish whether the antiserum, in a comparable technique to that used to demonstrate megakaryocyte and platelet localisation, reveals endothelial staining. Preliminary results suggest that endothelia of main and interlobular renal arteries show positive fluorescence (Fig. 3) . The staining appears to show cytoplasmic localisation with an additional subendothelial band closely related to the abluminal aspect of the cells. The exact parenchymal distribution of TSP-for example, details of glomerular localisation, and the relation of the apparent cytoplasmic to the extracellular staining remain to be determined.
Thrombospondin therefore represents another platelet protein synthesised within the megakaryocyte and released from the platelet after thrombininduced aggregation. Questions remain not only about its in vivo function but also about its relation to a similar molecule associated with vascular endothelium. The molecule and antisera directed against it may provide additional tools in the investigation of platelet function, thrombus formation and the complex interaction of platelets and the vessel wall. 
